Smith & Nephew SNATS (NYSE:SNN) Sees Strong Trading Volume – Time to Buy?

Smith & Nephew SNATS, Inc. (NYSE:SNN) saw unusually-high trading volume on Monday . 2,182,169 shares were traded during mid-day trading, an increase of 82% from the previous session’s volume of 1,197,121 shares.The stock last traded at $28.85 and had previously closed at $28.97.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. The Goldman Sachs Group reiterated a “buy” rating on shares of Smith & Nephew SNATS in a research report on Monday, May 25th. Sanford C. Bernstein set a $31.85 target price on shares of Smith & Nephew SNATS in a report on Monday, May 11th. Zacks Research cut shares of Smith & Nephew SNATS from a “hold” rating to a “strong sell” rating in a research report on Friday, August 7th. Kepler Capital Markets downgraded shares of Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a report on Thursday, June 4th. Finally, Barclays lowered shares of Smith & Nephew SNATS from an “equal weight” rating to an “underweight” rating in a research report on Wednesday, August 5th. Two investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Smith & Nephew SNATS has a consensus rating of “Hold” and a consensus target price of $30.93.

Smith & Nephew SNATS Stock Performance

The business has a 50 day simple moving average of $30.20 and a two-hundred day simple moving average of $31.57. The company has a current ratio of 2.14, a quick ratio of 1.11 and a debt-to-equity ratio of 0.62.

Smith & Nephew SNATS Dividend Announcement

The firm also recently declared a dividend, which will be paid on Friday, November 6th. Shareholders of record on Friday, October 2nd will be issued a $0.312 dividend. The ex-dividend date is Friday, October 2nd. This represents a yield of 205.0%.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of SNN. BlackRock Inc. purchased a new stake in Smith & Nephew SNATS in the second quarter valued at approximately $505,323,000. River Road Asset Management LLC increased its position in Smith & Nephew SNATS by 13.8% during the fourth quarter. River Road Asset Management LLC now owns 3,169,644 shares of the medical equipment provider’s stock worth $103,996,000 after purchasing an additional 384,926 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in Smith & Nephew SNATS by 5.2% during the fourth quarter. Goldman Sachs Group Inc. now owns 2,053,726 shares of the medical equipment provider’s stock worth $67,383,000 after purchasing an additional 100,697 shares during the period. Bank of America Corp DE purchased a new position in Smith & Nephew SNATS during the second quarter worth approximately $97,223,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Smith & Nephew SNATS in the 2nd quarter valued at $89,325,000. 25.64% of the stock is currently owned by hedge funds and other institutional investors.

About Smith & Nephew SNATS

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.